Welcome to the British Society for Nanomedicine
With the global benefits of the new science of nanomedicine growing each year, the British Society for Nanomedicine has been created to allow open access for industry, academia, clinicians and the public to news and details of ongoing research throughout the UK.
As a registered charity (Charity number 1151497) our mission includes the direct explanation of the ongoing science and commercial developments to allow the public to understand and stay in touch with this exciting area as it impacts future global healthcare. Scientists can also present their latest advances and highlight their work to industry and other researchers.
The Society is affiliated to other leading organisations involved with nanomedicine including : CLINAM, the European Technology Platform for Nanomedicine, the British Pharmacological Society and the American Society for Nanomedicine. For these and other important partnerships see our Links page.
You are welcome to join the Society through our membership page and we would be happy to hear your comments and about ways in which you want to be involved with the BSNM.
We would also like to acknowledge initial funding to create the Society from the Engineering and Physical Sciences Research Council
Meet the Trustees
Meet our Honorary Fellows
This special recognition is bestowed upon Trustees, as a heartfelt acknowledgment of longstanding and significant contributions to our Society and the field of nanomedicine as a whole.
Their dedication, leadership, and vision have played a crucial role in advancing our mission and supporting the growth of nanomedicine, leaving a lasting impact and paving the way forward.
“I’ve had the pleasure to be involved with nanomedicine research for over 15 years and during that time I have witnessed exponential growth in the field through the dedication of researchers in the UK and beyond. Nanomedicines continue to hold promise to address healthcare gaps for many diseases. Since its launch in Liverpool back in 2012, BSNM has provided a home for national and international nanomedicine research and provided a forum for knowledge sharing and new collaboration through its highly successful annual meetings. As nanomedicines continue to emerge, BSNM will remain at the forefront of science communication, and it is a real privilege to be awarded one of the first honorary fellowships of the society.”
“It has been extremely exciting to have been involved in the initial planning for the creation of BSNM, followed by the inaugural meeting in 2012, and the subsequent growth of the Society. Today it truly represents nanomedicine researchers in the United Kingdom but also has reach through to a number of global nanomedicine communities. We sought to create a truly inclusive Society that celebrated our science across the whole of the UK, and this has been a core principle that still lies at the heart of BSNM today. This has been a considerable effort from a large number of contributors, and I am truly humbled to be made an honorary Fellow.”